Printer Friendly

BELMAC FORMS NEW U.S. HOSPITAL PRODUCTS UNIT; FORMER BAXTER INTERNATIONAL EXECUTIVES TO RUN FIRST TARGETED AQUISITION: ROLL-A-SHEET

 TAMPA, Fla., April 22 /PRNewswire/ -- Today, Belmac's (AMEX: BLM) board of directors unanimously approved Belmac's first U.S. operating unit to market hospital products. Former Baxter International (BAX) marketing executives, Dale Phelps and Patrick Stoll will direct operations.
 Phelps, named General Manager of the Hospital Division, has been recently serving as a consultant to new and emerging companies in the hospital products industry. Previously, he spent 15 highly successful years with BAX rising to the rank of Vice President of Sales and Marketing for its Nutritional Division.
 Stoll was named Vice President of Sales and Marketing. Most recently, he was Sales Manger for National Accounts with Inter Tech Resources. Under his supervision Inter Tech experienced rapid sales growth in the disposable anesthesia mask market and became the market leader in less than five years. Previously, he spent 14 years in Corporate Sales at BAX.
 The charter for this new management group is to form a diversified mix of specialty products with a focus on niche markets within the hospital, surgi-center, nursing home and the home health care sectors. This new division was formed as part of Belmac's new direction to build growth and profitability through a series of strategic acquisitions operated by a seasoned management team.
 The first acquisition recommended by this group is the Roll-A-Sheet company of Dallas. Roll-A-Sheet is a product line consisting of a variety of disposable linens for high fluid loss areas within hospitals, such as the emergency room, ICU, CCU and burn units. Roll-A-Sheet products are more cost effective and sanitary than current practices. With its patented dispensing system, Roll-A-Sheet's goal is to gain a significant portion of the multi-million dollar institutional linen market.
 Belmac's board of directors approved the acquisition of an exclusive license to manufacture, market and distribute Roll-A-Sheet products for medical use. The terms of this acquisition consist primarily of an exchange of Belmac stock for the licensing rights. The closing date is subject to board approval and the satisfactory completion of due diligence.
 Belmac is pleased to initiate its U.S. presence with an innovative Roll-A-Sheet product line positioned by such an experienced marketing team. Belmac is continuing to explore additional acquisitions in the hospital market.
 Belmac is a pharmaceutical and health care company based in Tampa, Fla.
 -0- 4/22/93
 /CONTACT: Michael D. Price or Jill Figueredo of Belmac, 813-286-4401/
 (BLM)


CO: Belmac Corp. ST: Florida IN: MTC SU: PDT

JJ-AW -- FL016 -- 9337 04/22/93 11:01 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 22, 1993
Words:410
Previous Article:HUGHES SUPPLY DECLARES REGULAR QUARTERLY CASH DIVIDEND OF $.03 PER SHARE
Next Article:FORD MOTOR COMPANY/ASHA CORPORATION SIGN RESEARCH CONTRACT
Topics:


Related Articles
BELMAC ENTERS SPANISH MARKET WITH RIMAFAR, S.A.; PHARMACEUTICAL MANUFACTURING CAPABILITY VITAL LINK IN EUROPEAN DISTRIBUTION
BELMAC ACQUIRES RIMAFAR, S.A. IN SPAIN; PHARMACEUTICAL MANUFACTURING CAPABILITY A VITAL LINK IN EUROPEAN DISTRIBUTION
BAXTER TO SPIN OFF ITS ALTERNATE-SITE BUSINESSES TO SHAREHOLDERS
BELMAC CORPORATION TO ACQUIRE ITALIAN PHARMACEUTICAL COMPANY
BELMAC HEALTHCARE CORPORATION GRANTED PERMISSION TO MARKET U.S. DISPOSABLE LINEN LINE
BELMAC COMMENTS ON STOCK ACTIVITIES
BELMAC'S REVENUES UP 15 PERCENT -- CONTINUES TO IMPROVE BOTTOM LINE IN FIRST QUARTER OF 1994
Baxter Third-Quarter Net Income Grows 16 Percent; EPS Increases 14 Percent; Year-To-Date Cash Flow is $240 Million
SICOR restructures and extends marketing agreement with Baxter.
SICOR Restructures and Extends Marketing Agreement With Baxter.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters